{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T05:44:47Z","timestamp":1778996687388,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clozapine intoxication can be life-threatening. Outside of the common drug\u2013drug interactions, tobacco smoking, and caffeine consumption, infectious and inflammatory processes are important contributors to clozapine intoxication. Although this relationship has been reported previously, the literature is scant of proper research articles describing the presentation and management of this unpredictable interaction. Therefore, clinicians need to rely heavily on case reports describing clozapine intoxication caused by inflammation and\/or infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 64-year-old Caucasian woman known for schizophrenia was brought to the emergency department (ED) with severe signs and symptoms of clozapine intoxication (general deterioration, drowsiness, neutropenia, and ileus). She was on clozapine 700\u00a0mg daily amongst other medications. The clozapine dose was stable for over 3\u00a0years, and there were no recent changes in her medications. The initial culprit was determined to be an infectious\/inflammatory process of gastrointestinal origin with contribution from dehydration and constipation. Clozapine and norclozapine serum concentrations confirmed the intoxication: 1315\u00a0ng\/mL and 653\u00a0ng\/mL, respectively. She drastically improved with clozapine dose reduction and antibiotic therapy. She remained stable for years with clozapine 600\u00a0mg daily with stable clozapine serum levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case report illustrates the possibility of severe toxicity associated with an acute infectious and\/or inflammatory process in patients on clozapine therapy. Clinicians must maintain a high level of suspicion in patients taking clozapine who develop and an infectious and\/or inflammatory process. Constipation secondary to clozapine intoxication can exacerbate the initial intoxication process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-020-02660-x","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:18:27Z","timestamp":1612822707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clozapine intoxication with severe adverse effects induced by an inflammatory and infectious process: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Emmanuel","family":"Bebawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Wakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"2660_CR1","first-page":"CD009555","volume":"6","author":"S Subramanian","year":"2017","unstructured":"Subramanian S, Vollm BA, Huband N. Clozapine dose for schizophrenia. Cochrane Database Syst Rev. 2017;6:CD009555.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2660_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3109\/00048679809068332","volume":"32","author":"R Bell","year":"1998","unstructured":"Bell R, McLaren A, Galanos J, Copolov D. The clinical use of plasma clozapine levels. Aust N Z J Psychiatry. 1998;32(4):567\u201374.","journal-title":"Aust N Z J Psychiatry"},{"issue":"9","key":"2660_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/0004867412438871","volume":"46","author":"A Stark","year":"2012","unstructured":"Stark A, Scott J. A review of the use of clozapine levels to guide treatment and determine cause of death. Aust N Z J Psychiatry. 2012;46(9):816\u201325.","journal-title":"Aust N Z J Psychiatry"},{"key":"2660_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","volume":"192","author":"SR Clark","year":"2018","unstructured":"Clark SR, Warren NS, Kim G, et al. Elevated clozapine levels associated with infection: a systematic review. Schizophr Res. 2018;192:50\u20136.","journal-title":"Schizophr Res"},{"issue":"4","key":"2660_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.9758\/cpn.2016.14.4.323","volume":"14","author":"N Kar","year":"2016","unstructured":"Kar N, Barreto S, Chandavarkar R. Clozapine monitoring in clinical practice: beyond the mandatory requirement. Clin Psychopharmacol Neurosci. 2016;14(4):323\u20139.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"6","key":"2660_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/ijms17060863","volume":"17","author":"A Shirazi","year":"2016","unstructured":"Shirazi A, Stubbs B, Gomez L, et al. Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis. Int J Mol Sci. 2016;17(6):863.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2660_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4088\/JCP.v69n0509","volume":"69","author":"SE Palmer","year":"2008","unstructured":"Palmer SE, McLean RM, Ellis PM, Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008;69(5):759\u201368.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2660_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1124\/dmd.107.018747","volume":"36","author":"ET Morgan","year":"2008","unstructured":"Morgan ET, Goralski KB, Piquette-Miller M, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 2008;36(2):205\u201316.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"2660_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.2174\/138920012802138642","volume":"13","author":"LJ Dickmann","year":"2012","unstructured":"Dickmann LJ, Patel SK, Wienkers LC, Slatter JG. Effects of interleukin 1beta (IL-1beta) and IL-1beta\/interleukin 6 (IL-6) combinations on drug metabolizing enzymes in human hepatocyte culture. Curr Drug Metab. 2012;13(7):930\u20137.","journal-title":"Curr Drug Metab"},{"key":"2660_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pharmtox.46.120604.141059","volume":"46","author":"AE Aitken","year":"2006","unstructured":"Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. 2006;46:123\u201349.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2660_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1389200043335559","volume":"5","author":"KW Renton","year":"2004","unstructured":"Renton KW. Cytochome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab. 2004;5:235\u201343.","journal-title":"Curr Drug Metab"},{"issue":"9","key":"2660_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00213-015-3976-0","volume":"233","author":"G Hefner","year":"2016","unstructured":"Hefner G, Shams ME, Unterecker S, Falter T, Hiemke C. Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels. Psychopharmacology. 2016;233(9):1695\u2013705.","journal-title":"Psychopharmacology"},{"issue":"5","key":"2660_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/FTD.0b013e3182666c62","volume":"34","author":"KA Espnes","year":"2012","unstructured":"Espnes KA, Heimdal KO, Spigset O. A puzzling case of increased serum clozapine levels in a patient with inflammation and infection. Ther Drug Monit. 2012;34(5):489\u201392.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"2660_CR14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4088\/JCP.v65n0818a","volume":"65","author":"J De Leon","year":"2004","unstructured":"De Leon J. Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature. J Clin Psychiatry. 2004;65(8):1144\u20135.","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02660-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T22:20:06Z","timestamp":1612822806000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02660-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02660-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}